Alzheimer’s brain treatment shows promising results in new study Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using stem cells to program human immune cells for targeted treatment.
Alzheimer's rates have reached staggering number as experts call for change Alzheimer’s early detection is now more accessible with blood tests, as survey data shows nearly 80% of Americans want to know their risk before symptoms appear.
Paralyzed man with ALS is third to receive NeuraLink implant, can type with brain Brad Smith, an Arizona husband and father with ALS, has become the third person to receive Neuralink, the brain implant made by Elon Musk’s company.
Exercise can prevent cognitive decline even when energy lags, researchers discover Researchers at the University of Missouri discovered that exercise could make up for lost energy, pinpointing a link between liver function and cognitive decline.
Holding paper receipts for just 10 seconds can pose health risks, researchers warn Health researchers caution that Bisphenol S (BPS), an endocrine disruptor present in paper receipts, can rapidly absorb into the skin, leading to a notice of violation against major U.S. retailers.
'I'm a neurologist — here's why dementia is rising and how to reduce your risk’ Dr. Joel Salinas, a behavioral neurologist and associate professor at NYU Grossman School of Medicine, discusses what’s driving the spike in dementia cases and how to reduce risk.
Blood pressure and dementia risk share surprising link, study suggests Researchers in a new Chinese study discovered that “intensive blood pressure control" resulted in a 15% reduced dementia risk among participants and a 16% reduced risk of cognitive impairment.
Stem-cell therapy for Parkinson's shows 'strong promise' in relieving symptoms In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and bringing about improvement in motor function.
New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged' A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at least 400 mg of levodopa daily, tavapadon helped reduce motor fluctuations.
Smartphone use could reduce dementia risk in older adults, study finds The risk of dementia could decrease with consistent use of smartphones and other technology among older adults, according to a new study from Baylor University.